Monday, September 14, 2026

Unlocking the Future: How Ericsson’s AI-RAN and ISAC Technologies Are Shaping 6G Networks

Ericsson unveils next-gen network technologies aimed at the AI era, highlighting advancements in global telecommunications.

Why Galux is the Only Korean Bio-Tech Company on Forbes’ 2026 Asia’s 100 Most Promising Companies List?

Galaxy has been named one of Forbes' '100 Asian Companies to Watch in 2026', the only bio-healthcare firm among 9 Korean selections.

“The Envoy of WWIII?”: Trump’s Hardline Nominee Michelle Steel Arrives on a Collision Course with Seoul

Michelle Park Steel's nomination as U.S. ambassador to South Korea raises hopes and concerns over her stance on China and North Korea.

Tag: pharmaceutical

North KoreaKoreaKimMilitaryAISouth Koreamarketrelationsdevelopment

Roche’s HM17321: The Revolutionary Obesity Drug Transforming Weight Loss and Muscle Preservation

Roche focuses on Hanmi Pharmaceutical's obesity drug candidate HM17321 due to promising preclinical results for weight loss and muscle preservation.

Yuhan Corp. Signs $874 Million API Supply Deal With Global Pharmaceutical Company

Yuhan Corp. has secured a long-term active pharmaceutical ingredient supply contract worth $874 million with a global pharmaceutical company, expanding its overseas export business.

How DongKoo Bio & Pharma Maintains Its Dermatology Dominance While Expanding into New Fields

DongKoo Bio & Pharma expands its business into specialized medicine markets, leveraging its prescription competitiveness in dermatology and urology.

JW Pharmaceutical Files for South Korea Phase 3 Trial of Once-Every-Two-Weeks Obesity Drug

JW Pharmaceutical is seeking to advance Bofanglutide into a South Korean Phase 3 trial, aiming to halve the dosing frequency of GLP-1 obesity treatments from once weekly to once every two weeks.

How Hanmi Pharmaceutical’s AI Platform is Revolutionizing Obesity Drug Development in 2026

Hanmi Pharmaceutical leverages AI for drug discovery, developing innovative obesity treatments and advancing to clinical trials.

How Celltrion’s Truxima Dominates the U.S. Rituximab Market: A 4-Month Winning Streak

Celltrion's Truxima leads the U.S. rituximab market for four months, gaining FDA interchangeability status, boosting growth prospects.

[Exclusive] HLB’s Liver Cancer Drug Clears Camrelizumab CMC Review, but Hengrui Manufacturing Facility Becomes New Hurdle

HLB's liver cancer drug approval faces delays due to FDA findings at Hengrui's facility, despite resolution of previous issues.

Centellian24 ranks No. 1 in PDRN eye cream category at U.S. Amazon Prime Day

Centellian24 by DongKook Pharmaceutical topped Amazon's eye cream category during Prime Day, with sales up over 900% from last year.

Discover the New Turbineu Double Action Aerosol: The Ultimate Solution for Athlete’s Foot in 2026

Dong-A Pharmaceutical has launched 'Turbinew Double Action Aerosol', an easy-to-use spray treatment for athlete's foot.

Samsung Bioepis Signs Teva Deal to Commercialize Opuviz in Canada, Expanding North American Biosimilar Business

Samsung Bioepis partners with Teva to launch ophthalmology biosimilar Opuviz in Canada, enhancing access to treatments for patients.

SK Bioscience Achieves WHO PQ Certification: What This Means for Global Vaccine Supply

SK Bioscience completed WHO's triennial review for its vaccines, enhancing international trust in its quality and operational systems.

Mexico Recognizes South Korea’s MFDS: What This Means for Drug Approvals

Mexico recognizes South Korea's MFDS as a reference authority, streamlining drug approvals and enhancing market access for Korean firms.

ViOL Medical Expands China Push With New Sylfirm X Supply Deal With Sihuan Pharmaceutical

ViOL Medical expands its partnership with Sihuan Pharmaceutical to enhance the market presence of its Sylfirm X device in China.

Samjin Pharmaceutical and Aribio Lab Form Vaccine Partnership to Advance Joint Development and Commercialization

Samjin Pharmaceutical partners with Aribio Lab to develop and commercialize vaccines, enhancing market adoption and R&D capabilities.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.